Birdwatch Note Rating
2024-05-01 09:04:39 UTC - HELPFUL
Rated by Participant: 09B00E68BD89E4BC9E01614DC7CA17E94B70AF6E7AECAC08D9DD6F4407E5A153
Participant Details
Original Note:
EBC-46 is a compound with potential anti-cancer properties that has been successfully used in veterinary medicine and is currently being studied for use in humans. However, the claim of it killing cancer in 48 hours should be viewed in the context of ongoing research. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268252/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182759/ https://www.europeanpharmaceuticalreview.com/news/175005/novel-cancer-therapeutic-synthesised-by-stanford-researchers/
All Note Details